Finance

Lists
GTLB:NASDAQ
Gitlab Inc
$47.15
-5.38%
(-2.68) 1D
$47.19
+0.08% (+0.040)
After hours
Closed: Sep 8, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GTLB...
Open
$48.95
High
$49.08
Low
$46.84
Mkt. cap
7.86B
Avg. vol.
5.44M
Volume
4.38M
52-wk high
$55.55
52-wk low
$18.73
EPS
-$0.31
Beta
0.99
Shares outstanding
165.50M
No. of employees
3K
Open
$48.95
High
$49.08
Low
$46.84
Mkt. cap
7.86B
Avg. vol.
5.44M
Volume
4.38M
52-wk high
$55.55
52-wk low
$18.73
EPS
-$0.31
Beta
0.99
Shares outstanding
165.50M
No. of employees
3K
News stories
From web sources and news partners
Profile
GitLab Inc. is an American company that operates and develops GitLab, an open-core DevOps software package that can develop, secure, and operate software. GitLab includes a distributed version control system based on Git, including features such as access control, bug tracking, software feature requests, task management, and wikis for every project, as well as snippets. The open-source software project was created by Ukrainian developer Dmytro Zaporozhets and Dutch developer Sytse Sijbrandij. In 2018, GitLab Inc. was considered to be the first partly Ukrainian unicorn. GitLab has an estimated over 30 million registered users, including 1 million active licensed users. There are more than 3,300 code contributors and team members in 60+ countries. Wikipedia
About Gitlab Inc
CEOBill Staples
Employees2.58K
Founded2014
HeadquartersSan Francisco, California, United States
SectorSoftware
Websiteabout.gitlab.com
Analyst ratings
Based on 22 analysts giving stock ratings to GTLB in the past 3 months
Hold
Buy
6
Hold
15
Sell
1
12-month forecast
Based on 22 Wall Street analysts offering 12 month price targets for GTLB in the last 3 months.
Highest
Current $47.15
$70.00 (+48.46%)
Average
$53.61 (+13.70%)
Lowest
$44.00 (-6.68%)
Analyst
Recommendation
Action
Price target
Projected
Date
Adam Tindle
Raymond James
Hold
Maintained
-
-
09/02/2026
Gregg Moskowitz
Mizuho Securities
Hold
Maintained
$47.00
-0.3%
09/02/2026
Radi Sultan
UBS
Hold
Maintained
$50.00
+6%
09/02/2026
Miller Jump
Truist Financial
Hold
Reiterated
$48.00
+1.8%
09/02/2026
Peter Weed
Bernstein
Buy
Maintained
$60.00
+27.3%
09/02/2026
Blair Abernethy
Rosenblatt Securities
Buy
Maintained
$55.00
+16.6%
09/02/2026
Kingsley Crane
Canaccord Genuity
Buy
Maintained
$70.00
+48.5%
09/02/2026
Mike Cikos
Needham
Buy
Reiterated
$65.00
+37.9%
09/02/2026
Sanjit Singh
Morgan Stanley
Hold
Reiterated
$57.00
+20.9%
09/03/2026
Rob Owens
Piper Sandler
Hold
Maintained
$52.00
+10.3%
09/02/2026
Ryan MacWilliams
Wells Fargo
Hold
Reiterated
$50.00
+6%
09/02/2026
Koji Ikeda
Bank of America Securities
Hold
Reiterated
$54.00
+14.5%
09/02/2026
Jason Celino
KeyBanc
Hold
Maintained
-
-
09/02/2026
Raimo Lenschow
Barclays
Sell
Maintained
$47.00
-0.3%
09/01/2026
Matthew Hedberg
RBC Capital
Hold
Maintained
$46.00
-2.4%
09/02/2026
Jason Ader
William Blair
Hold
Upgraded
-
-
09/02/2026
Shrenik Kothari
Robert W. Baird
Buy
Maintained
-
-
09/01/2026
Derrick Wood
TD Cowen
Hold
Reiterated
$55.00
+16.6%
09/02/2026
Jonathan Ruykhaver
Cantor Fitzgerald
Hold
Reiterated
$50.00
+6%
09/02/2026
Lucky Schreiner
D.A. Davidson
Hold
Maintained
$55.00
+16.6%
09/01/2026
Nick Altmann
BTIG
Buy
Reiterated
$60.00
+27.3%
09/02/2026
Brian Essex
J.P. Morgan
Hold
Maintained
$44.00
-6.7%
08/26/2026
Joshua Tilton
Wolfe Research
Buy
Maintained
$36.00
-23.6%
06/03/2026
Alex Zukin
Wolfe Research
Buy
Reiterated
$36.00
-23.6%
06/02/2026
Andrew Sherman
TD Cowen
Hold
Reiterated
$29.00
-38.5%
06/03/2026
Howard Ma
Guggenheim
Hold
Downgraded
-
-
04/08/2026
Last report
Sep 1, 2026
Fiscal period
Q2 2027
EPS / Est. (USD)
$0.24 / $0.18
+33.60%beat
Revenue / Est. (USD)
286.25M / 273.36M
+4.72%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Revenue
244.35M
260.40M
264.16M
286.25M
Cost of goods sold
32.22M
34.83M
37.49M
44.24M
Cost of revenue
32.22M
34.83M
37.49M
44.24M
Research and development expenses
68.72M
68.96M
71.48M
85.33M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
155.77M
159.23M
170.94M
189.73M
Operating expense
224.49M
228.19M
242.42M
275.07M
Total operating expenses
256.71M
263.02M
279.91M
319.30M
Operating income
-12.36M
-2.62M
-15.75M
-33.05M
Other non operating income
-3.97M
-43.00K
-281.00K
3.59M
EBT including unusual items
-6.99M
391.00K
-3.55M
-39.33M
EBT excluding unusual items
-6.99M
2.94M
-3.55M
-15.44M
Income tax expense
1.81M
3.90M
2.03M
-3.20M
Effective tax rate
-25.92%
998.47%
-57.29%
8.12%
Other operating expenses
-
-
-
-
Net income
-8.28M
-2.60M
-4.97M
-36.84M
Net profit margin
-3.39%
-1.00%
-1.88%
-12.87%
Earnings per share
0.25
0.30
0.23
0.24
Interest and investment income
11.70M
11.63M
11.95M
12.20M
Interest expense
-
-
-
-
Net interest expenses
11.70M
11.63M
11.95M
12.20M
Depreciation and amortization charges
-
-
-
-
EBITDA
-11.47M
-1.71M
-14.44M
-31.69M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps